CVS Health Corporation $CVS Holdings Raised by University of Texas Texas AM Investment Management Co.

University of Texas Texas AM Investment Management Co. increased its stake in shares of CVS Health Corporation (NYSE:CVS) by 7,527.1% during the 3rd quarter, Holdings Channel.com reports. The fund owned 46,754 shares of the pharmacy operator’s stock after purchasing an additional 46,141 shares during the quarter. University of Texas Texas AM Investment Management Co.’s holdings in CVS Health were worth $4,006,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. BlackRock Inc. bought a new stake in CVS Health in the second quarter valued at approximately $12,747,462,000. State Street Corp boosted its stake in shares of CVS Health by 26.3% during the second quarter. State Street Corp now owns 74,927,064 shares of the pharmacy operator’s stock valued at $7,751,205,000 after purchasing an additional 15,604,883 shares during the period. Wellington Management Group LLP grew its holdings in shares of CVS Health by 49.8% in the second quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator’s stock worth $3,496,725,000 after purchasing an additional 11,233,381 shares during the last quarter. Bank of America Corp DE grew its holdings in shares of CVS Health by 148.0% in the second quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock worth $2,398,868,000 after purchasing an additional 13,836,701 shares during the last quarter. Finally, Pzena Investment Management LLC purchased a new position in shares of CVS Health in the second quarter worth $1,217,558,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health News Roundup

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Executive Vice President Prem Shah bought 23,855 shares for about $2 million, increasing his direct stake by 36.9%. The sizable purchase may signal confidence in CVS’s prospects. SEC filing
• Positive Sentiment: CVS beat third-quarter earnings and revenue estimates and raised its 2026 outlook, with Aetna’s recovery among the factors supporting the improved outlook. Q3 earnings call coverage
• Neutral Sentiment: UBS lowered its price target to $107 but maintained a Buy rating, indicating continued optimism while reflecting a more cautious valuation. UBS rating
• Negative Sentiment: The planned separation of the retail pharmacy business from the insurance and pharmacy-benefit operations by 2028 has raised questions about execution, costs, and the value of the two businesses. The announcement overshadowed the earnings beat and was followed by a sharp selloff. Breakup and stock reaction
• Negative Sentiment: Additional concerns include weaker Medicare ratings and AM Best placing ratings for Aetna subsidiaries under review, creating uncertainty around the insurance business. Medicare ratings coverage

CVS Health Price Performance

Shares of CVS Health stock opened at $83.76 on Monday. The business has a 50 day moving average of $90.37 and a 200 day moving average of $88.89. CVS Health Corporation has a 52 week low of $69.51 and a 52 week high of $110.68. The company has a market cap of $107.17 billion, a PE ratio of 9.75, a P/E/G ratio of 0.73 and a beta of 0.58. The company has a quick ratio of 0.66, a current ratio of 0.85 and a debt-to-equity ratio of 0.71.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share for the quarter, beating the consensus estimate of $1.65 by $0.44. The business had revenue of $108.40 billion for the quarter, compared to analysts’ expectations of $104.72 billion. CVS Health had a net margin of 2.62% and a return on equity of 13.65%. The firm’s revenue for the quarter was up 5.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.60 earnings per share. As a group, equities research analysts forecast that CVS Health Corporation will post 8.25 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd were paid a dividend of $0.6650 per share. The ex-dividend date of this dividend was Thursday, October 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.2%. CVS Health’s payout ratio is presently 30.97%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the stock. Barclays lowered their price target on shares of CVS Health from $108.00 to $107.00 and set an “overweight” rating for the company in a report on Thursday. Robert W. Baird set a $107.00 price target on shares of CVS Health in a report on Thursday, August 6th. Argus raised their price target on shares of CVS Health from $104.00 to $114.00 and gave the stock a “buy” rating in a report on Wednesday, August 19th. JPMorgan Chase & Co. upped their price objective on shares of CVS Health from $111.00 to $118.00 and gave the company an “overweight” rating in a research note on Wednesday, August 12th. Finally, Truist Financial increased their target price on shares of CVS Health from $108.00 to $118.00 and gave the stock a “buy” rating in a report on Tuesday, July 14th. Twenty-two investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $108.25.

Insider Buying and Selling at CVS Health

In related news, EVP Prem Shah purchased 23,855 shares of CVS Health stock in a transaction that occurred on Friday, November 6th. The shares were bought at an average price of $83.89 per share, for a total transaction of $2,001,195.95. Following the completion of the transaction, the executive vice president directly owned 88,516 shares of the company’s stock, valued at $7,425,607.24. This represents a 36.89% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.85% of the company’s stock.

About CVS Health

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division.

The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

Founded in 1963 as Consumer Value Stores in Lowell, Massachusetts, the company expanded from a retail pharmacy business into a broad health care organization and adopted the CVS Health name in 2014.